Author:
Liu Wen-jian,Wang Hua,Wang Wei-da,Zhu Meng-yuan,Liu Cheng-cheng,Wang Jing-hua,Lu Yue
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. van den Berg, H. Asparaginase revisited. Leukemia & lymphoma 52, 168–178, doi: 10.3109/10428194.2010.537796 (2011).
2. Asselin, B. L. et al. In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase. Cancer research 49, 4363–4368 (1989).
3. Ettinger, L. J., Kurtzberg, J., Voute, P. A., Jurgens, H. & Halpern, S. L. An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia. Cancer 75, 1176–1181 (1995).
4. Muller, H. J. et al. Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols. British journal of haematology 110, 379–384 (2000).
5. Rizzari, C. et al. A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia. Haematologica 91, 24–31 (2006).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献